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Abstract
The investigation of mouse flank tumours by magnetic resonance imaging
(MRI) is limited by the achievable spatial resolution, which is generally limited
by the critical problem of signal-to-noise ratio. Sensitivity was improved by
using an optimized solenoid RF micro-coil, built into the animal cradle. This
simple design did not require extensive RF engineering expertise to construct,
yet allowed high-resolution 3D isotropic imaging at 60 × 60 × 60 µm3 for
a flank tumour in vivo, revealing the heterogeneous internal structure of the
tumour. It also allowed dynamic contrast enhanced (DCE) experiments and
angiography (MRA) to be performed at 100 × 100 × 100 µm3 resolution. The
DCE experiments provided an excellent example of the diffusive spreading of
contrast agent into less vascularized tumour tissue. This work is the first step
in using high-resolution 3D isotropic MR to study transport in mouse flank
tumours.
Introduction
The investigation of animal models using MRI allows non-invasive access to functional,
anatomical and physiological information. An inherent problem with studying small animals,
e.g. mice, is the greatly reduced size of anatomical structures which necessitates the use of high
spatial resolutions. The spatial resolution is generally not limited by the gradient encoding
power of the imager but rather by the critical signal-to-noise ratio.
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Previous MRI studies of mouse flank tumours have mainly used either whole mouse
volume resonators or surface coils. Volume resonators have the advantage of good B1
homogeneity, with the disadvantage of having a very low effective filling factor (tumour
size of ∼4 mm, with regard to resonator size of ∼35 mm diameter). The resolution achieved
with a mouse volume resonator typically ranges up to 200 × 200 µm2 with 1–2 mm slice
thickness (Kiessling et al 2005, Graff et al 2005, Yankeelov et al 2006).
Of course the signal to noise can be improved by signal averaging, but for in vivo studies
the duration an animal can be anaesthetized is limited, and long durations are not desirable.
Also, in experiments such as dynamic contrast enhanced (DCE) MRI the temporal resolution
of scans is important; therefore, this is not usually a significant option.
Other ways to improve signal-to-noise ratio include working at higher magnetic fields or
improving the sensitivity of the NMR signal detection, for example by the use of phased array
coils or cyro-cooled coils. Recently, a transmit–receive super-conducting surface coil (Ginefri
et al 2005) has been developed, which for mouse tumours achieved resolutions up to 59 ×
59 µm2 with 300 µm slice thickness, at 1.5 T.
A simpler and often overlooked alternative to these options is to fully optimize the
geometry and type of RF coil to suit the sample/region of interest. In the case of in vivo
imaging of flank tumours on mice, these tumours are small (∼2–5 mm diameter) and protrude
out from the side of the animal (∼3–4 mm). The best filling factor possible would be achieved
by placing the flank tumour fully inside an RF coil of a slightly larger diameter, with the
tumour as far as possible contained within the coil. With the animal lying head to foot inside
the magnet (parallel to the B0 field), this would require the axis of the RF coil be perpendicular
to the axis of the B0 field. The fundamentals of NMR require that the B1 field, produced by
the RF coil, be perpendicular to the B0 magnetic field. Therefore, the ideal coil geometry
would be a solenoid, as the B1 field of a solenoid runs along its axis.
The choice of a solenoid has many natural advantages. First, the solenoid is the coil design
that allows for the best NMR sensitivity (Mispelter et al 2006). For example, compared to a
saddle coil of the same dimensions, the sensitivity performance of a solenoid is approximately
three times greater (Hoult and Richards 1976). Indeed solenoids are widely used in solid state
NMR, where sample loading is not an issue and NMR sensitivity is paramount. Also, small
diameter solenoids are simple to construct, and produce high B1 homogeneity (Hoult and
Richards 1976). The practical size of an RF solenoid coil is limited by the need for the total
length of conductor to be small compared to the wavelength of RF radiation used, otherwise
phase differences between different parts of the coil lead to interference of B1 contributions.
At high frequency this limits the use of solenoid RF coils to very small diameters.
This paper describes the use of a solenoid micro-coil design that has been optimized
for imaging mouse flank tumours in vivo. The simple design does not require extensive RF
engineering expertise to construct and implement, yet can greatly improve sensitivity and
hence spatial and/or temporal resolution.
Material and methods
Solenoid coil and animal cradle
The high sensitivity of a small diameter solenoid required that it be constructed as an integral
part of a purpose-built animal cradle, to provide it with mechanical stability (see figure 1). The
top of the cradle consists of a thin flat platform, with a hole at the centre, entering to a hollow
cylinder (inner diameter 5.5 mm and outer diameter 7.0 mm). Underneath the top platform,
the solenoid coil was wound around the outside of the cylinder. This allows the mouse to
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Figure 1. Diagram of animal cradle with built-in solenoid RF coil. (a) Side view. (b) Perspective
view. (c) End view of cradle showing how it fits into 60 mm diameter of the micro-imaging
gradient set. (d) Resonant circuit design.
be lain on the platform, with the flank tumour placed carefully inside the cylinder, hence
inside the solenoid coil. Anaesthetic was administered via a face mask and the animal’s body
temperature maintained with a close-fitting water jacket. The cradle with a mouse and water
jacket in position was designed to fit inside the 60 mm inner diameter of the micro-imaging
gradient set (Bruker, BG-6).
The solenoid coil was constructed of 0.8 mm diameter susceptibility matched wire
(aluminium core coated with copper), which has lower magnetic susceptibility than copper
alone (Haase et al 2000). This wire is commonly used in solid-state NMR spectrometers to
reduce distortion of the B0 field. The solenoid coil has an inner diameter of 7 mm and is 5 mm
in height with two and a half turns, which is close to the optimal design for a solenoid coil
(Haase et al 2000). The total length of the conductor was 55 mm, compared to a RF wavelength
of 999 mm at 300 MHz, thereby obeying the rule of thumb set out by Chen and Hoult (1989)
for a solenoid coil to have good B1 homogeneity.
Figure 1(d) shows the RF circuit design used (Mispelter et al 2006, Fukushima and Roeder
1981). This consists of two variable air capacitors (C1 and C3) of 0.6 pF to 6.0 pF (Johanson),
accessed by tuning rods. C3 is a 1.8 pF ceramic chip capacitor (Temex). The solenoid
coil was operated in transmit/receive mode using the standard scanner electronics. Unlike
a receive-only coil this mode does not require active decoupling, thus greatly simplifying
construction.
Animal preparation
Imaging was performed on female mice (CD1-nu, mean weight 20 g) with established A431
epidermoid carcinoma xenografts of around 5 mm diameter (ATCC CRL-1555). The mice
were anaesthetized using 2–3% isofluorane, in a 70/30 mixture of nitrous and oxygen, applied
via a face mask. The body temperature was maintained at 37 ◦C, using a water jacket.
Temperature, respiration and ECG were monitored using a BIOPAC system (Goleta, CA,
USA). A bolus of contrast agent was manually administered intravenously via a tail vein
cannulation. The contrast agent (Magnevist, Schering, Germany) was used at a dose of
1.0 mmol Gd kg−1 body weight.
MR imaging
Imaging was performed on a Bruker Biospec Avance system using a 7T horizontal 30 cm
bore magnet. A Bruker micro-imaging gradient insert (BG-6), inner diameter 60 mm, was
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used, with 100 A amplifiers, giving a maximum gradient of 1000 mT m−1 with a rise time
of 50 µs.
In vivo high spatial resolution (HSR) images were acquired using a T1 weighted 3D
FLASH gradient echo sequence with the following parameters: isotropic pixels 60 × 60 ×
60 µm3, field of view 7.7 × 6.0 × 6.0 mm3 and an acquisition matrix of 128 × 100 × 100.
The sequence used an echo time of 3.5 ms and a recovery time of 100 ms, a bandwidth of
50 kHz and a flip angle of 30◦. Total scan time of 50 min.
In order to image the slow flow in the tumour vessels a multi-slice 2D flow compensated
gradient echo sequence was used, with the slices perpendicular to the axis of the coil. Isotropic
voxels were acquired with 100 × 100 µm2 in-plane resolution and 60 sequential slices of
100 µm thickness. The increased rate of replacement of blood in these thin slices helps to
resolve slow flowing vessels. The echo time used was 5 ms and the recovery time was 40 ms
with a bandwidth of 50 kHz and 8 averages. Total scan time was 22 min.
In vivo DCE imaging of flank tumours was performed using a 3D FLASH sequence with
the following parameters: isotropic voxels 100 × 100 × 100 µm3, field of view 8 × 8 ×
8 mm3 and an acquisition matrix of 80 × 80 × 80. This sequence used an echo time of 3.5 ms
and a recovery time of 25 ms, a bandwidth of 50 KHz and a flip angle of 30◦. Images
were acquired immediately before and every 10 min post injection. As the tumour is mainly
contained within the coil, a much reduced FOV can be used, helping to reduce the scan time.
Placing the read direction along the coil axis removes the problem of signal from the body
of the mouse folding back in to the image. The same sequence parameters were also used to
image a phantom in order to assess the image homogeneity of the coil.
Results
Figure 2 shows gradient echo images acquired with a cylindrical phantom of aqueous copper
sulfate, illustrating good image homogeneity. The profiles of normalized signal intensity are
also shown, relative to the cradle position. The calculated uniformities, within 10% of the
minimum or maximum, were 3.7 mm perpendicular and 2.7 mm parallel to the axis of the
coil, as used by Alecci et al (2003) and Giovannetti et al (2004). The Q factor was measured
as the ratio of the resonant frequency to the frequency bandwidth at −3 dB, using a network
analyser (Agilent 8712ET), with the coil tuned and matched to 300 MHz and 50 . The
−3 dB bandwidth was located at 3 dB below the reference level (Fan et al 2006). The loaded
and unloaded Q factor of the phantom was measured as 118 and 129.
An example of a high-resolution scan of a mouse flank tumour, measured using the
solenoid coil, is shown in figure 3. This 3D dataset has isotropic pixel resolution of 60 × 60 ×
60 µm3. At this high resolution the 3D heterogeneous structure of the tumour is apparent. It is
easy to identify tumoural tissue, normal tissue and the rim of the tumour. Such high-resolution
images reveal structures at a histological scale and can be used to monitor and study tumour
development and response to therapy in preclinical development.
The DCE experiment was performed with manual intravenous injection of a bolus of
contrast agent. Figure 4(a) shows a cross-section through the centre of the 3D dataset of the
tumour. Following injection of contrast agent there is a rapid signal enhancement at the tumour
rim. The contrast agent can then be seen to be transported radially into the tumour tissue,
before being washed out. Figure 4(c) shows the signal profile of a line through the centre of
the tumour, which clearly shows the radial spreading of contrast agent into the tumour. The
traditional way of analysing DCE data is via time profile plots of signal or concentration.
Figure 4(d) shows such plots taken from different points in the tumour.
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Figure 2. Gradient echo images obtained of phantom of aqueous copper sulfate. (a) Vertical
image showing the position of the solenoid coil and the animal platform. (b) Vertical signal
profiles through phantom. (c) Horizontal image through centre of coil. (d) Horizontal signal
profile through phantom. Imaged using 3D FLASH sequence: Te 3.5 ms, Tr 25 ms, flip-angle 30◦,
isotropic voxels 100 × 100 × 100 µm3, field of view 8 × 8 × 8 mm3, matrix of 80 × 80 × 80.
Solutions T1 = 86.7 ms and T2 = 74 ms.
Figure 3. A 3D isotropic 60 × 60 × 60 µm3 T1 weighted high-resolution scan of mouse flank
tumour. The field of view of the above image is 7.7 × 7.7 mm2. The dotted ellipse indicates the
location of the tumour tissue.
In order to better understand the role of vascular delivery of the contrast agent in this
process, a high-resolution angiography sequence was used to identify vessels in the tumour.
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Figure 4. A 3D isotropic 100 × 100 × 100 µm3 angiogram of mouse flank tumour, displayed as
a maximum intensity projection (MIP). The MIP is rotated in 24◦ steps to highlight the 3D ‘claw’
like structure of vessels.
Figure 5 shows images from a 3D high resolution (100 × 100 × 100 µm3) maximum intensity
projection (MIP) angiograghy of a mouse flank tumour. Large and small vessels are visible in
a ‘claw’ like encompassment of the tumour.
Discussion
There is an increasing appreciation of the role of spatiotemporal heterogeneity of tumours in
cancer therapy (Jain 1990). Even for the low molecular weight drugs currently dominating
clinical practice the relevance of this heterogeneity has been demonstrated convincingly in
the clinic: Lankelma and colleagues demonstrated that in breast cancer variations in cancer
cell density can lead to heterogeneity of drug distribution, i.e. doxorubicin had not reached
denser areas of breast tumours even 24 h after therapeutic administration making it likely that
potentially sub therapeutic drug levels may be linked to drug resistance and therapeutic failure
(Lankelma et al 1999). As transport in tumours is typically diffusion limited such barriers
would be expected to potentially affect higher MW agents such as antibodies or nanomedicines
significantly more (Cassidy and Scha¨tzlein 2004). We believe that isotropic high-resolution
three-dimensional imaging of transport process in tumours can help to better understand the
role of heterogeneity for the transport of therapies in the tumour.
Typically, DCE MRI experiments on mouse flank tumours are performed using high in-
plane resolution images, with a large slice thickness (typically, 200 × 200 µm2, with 1–2 mm
slice thickness). This gives a false sense of resolution, because of course any heterogeneity
is averaged over the whole of the slice direction. The DCE data shown in figure 4 improves
on this by imaging using 100 × 100 × 100 µm3 isotropic voxels, allowing high-resolution
three-dimensional imaging of transport processes within the tumour.
MR angiography has been previously used to characterize intratumoural vasculature in
mice (Fink et al 2003) and correlations made with histology (Graff et al 2005). Though,
with a spatial resolution of 166 × 206 × 329 µm3, only larger vessels could be visualized.
Such tumour angiography, as demonstrated in this paper, with resolution of 100 × 100 ×
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Figure 5. In vivo 3D isotopic datasets of mouse flank tumour, voxel size 100 × 100 × 100 µm3.
(a) Cross-section through 3D dataset pre- and 10 min, 20 min, 40 min, 60 min post-injection.
Radial diffusion of contrast agent into tumour is apparent. (b) Position of voxels and line profile.
(c) Line profile of signal intensity. (d) Time course of signal taken at selected locations.
100 µm3, identical to that of the DCE data, is better able to detect much smaller vessels
(figure 5), in this case highlighting the claw-like encompassment of the tumour. This could
potentially allow serial observations of anti-vascular effects caused by vascular disrupting
agents (VDA) (Siemanns et al 2004).
Currently, the most commonly used method for the measurement of therapeutic response
in preclinical development is the determination of the volume of subcutaneously inoculated
tumours in mice based on calliper measurements. While having the advantage of simplicity
this is prone to error due to the approximation of tumour shape to an ellipsoid (Cornelissen
et al 2005). It is common to use MRI 3D based volumetry to size human tumours. Recently,
this has been applied to sizing mouse tumours, though using a low spatial resolution (500 ×
1000 × 1000 µm3) (Cornelissen et al 2005). Using high-resolution isotopic MRI images,
such as presented in this paper, would greatly improve the accuracy of serial tumour volume
measurements in mice. Furthermore, there is an increasing need to develop methods that allow
monitoring of early responses which may not immediately translate into substantial tumour
volume changes and to relate these to tumour structure and histology.
The DCE data shown in figure 4 are worthy of further comment, as the high-resolution
3D dataset shows slow radial spreading of contrast agent from regions of high-to-low
concentration, i.e. from the well-vascularized periphery, towards the centre of the tumour.
This suggests that as well as perfusion, the process of Fickian diffusion may also contribute to
transport. The ability to monitor such process is of potential therapeutic relevance given that
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transport in the tumour is likely to be diffusion limited due to the reduction of perfusion and
convective transport brought about through the increased interstitial fluid pressure (IFP) in the
tumour (Minchinton and Tannock 2006). To assess this, an estimate is needed of the possible
displacement of contrast agent due to diffusion over the duration of the experiment. This
requires knowledge of the apparent diffusion coefficient (ADC) of magnevist, Dm within the
tumour tissue. Although this value has not yet been experimentally determined, an estimate
can be made from other literature data. Osuga and Han (2004) have given an approximate value
for the diffusion coefficient of magnevist in water as 0.4 × 10−9 m2 s−1, and the self-diffusion
coefficient of water is known to be 2.1 × 10−9 m2 s−1. In tumour tissue the apparent diffusion
coefficient (ADC) of water molecules is reduced to between 0.6 and 1.0 × 10−9 m2 s−1 (Herneth
et al 2003). We therefore estimate Dm to be approximately 0.1 to 0.2 × 10−9 m2 s−1. Giving
magnevist a root-mean-squared displacement, xrms, in 60 minutes of between 1.4 mm and
2 mm (using xrms =
√
6Dmt). This is approximately the same length scale as the spreading
seen in figures 4(a) and (c), i.e. over tens of voxels, suggesting the possibility of Fickian
diffusion as an additional transport mechanism. Currently, DCE time courses of individual
voxels, such as shown in figure 4(d), are modelled using compartmental models of perfusion
(Tofts and Kermode 1989, Tofts 2003). These models consider perfusion in each voxel in
isolation, and assume no transport of contrast agent occurs between neighbouring voxels over
time. Fickian diffusion of contrast agent across voxels would violate this assumption, leading
to inaccurate model predictions.
Conclusion
This paper has described the use of a simple solenoid micro-imaging coil for in vivo imaging of
cancerous flank tumours on mice. The solenoid being the optimal geometry for this situation,
giving good B1 homogeneity and high sensitivity. The improved sensitivity allowed high-
resolution isotropic imaging of up to 60 × 60 × 60 µm3 of in vivo flank tumours, which
is currently the highest resolution demonstrated in the literature. The high-spatial resolution
clearly revealed the 3D heterogeneity of the tumour.
The coil has also been used to obtain isotropic 3D MRI DCE experiments (100 × 100 ×
100 µm3) and MR angiography (100 × 100 × 100 µm3) of mice flank tumours in vivo. The
angiograph showed large and small vessels in a ‘claw’ like encompassment of the tumour. The
DCE dataset clearly demonstrated the slow transport of contrast agent radially into the poorly
vascularized centre of the tumour, from the better vascularized outer rim and highlighted the
extensive heterogeneity of transport within the tumour.
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